Phio Pharmaceuticals Corp expected to post a loss of 32cents a share - Earnings Preview

Phio Pharmaceuticals

21/03/2022 11:06

* Phio Pharmaceuticals Corp  PHIO.OQ   PHIO.O  is expected
to show
no change in quarterly revenue when it reports  results on March
23 (estimated). 
    * ​Refinitiv's mean analyst estimate for Phio
Pharmaceuticals Corp
is for a loss of 32 cents per share. For the same quarter last
year, the company reported a loss of 41 cents per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6​, above​ its last closing price
of $0.85. ​​​

This summary was machine generated March 21 at 11:06 GMT.  All
figures in US dollars  unless otherwise stated